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Introduction
Alternative splicing is a regulatory mechanism that allows genes 
to encode for multiple protein isoforms that often play different 
biological roles (Maniatis and Tasic, 2002; Black, 2003; Stetefeld 
and Ruegg, 2005). It arises from the optional use of alter  native 
splice sites within a pre-mRNA. In mammals, the signals that 
defi  ne the beginning and the end of an intron are ill defi  ned, and 
the authentic splice sites can be identifi  ed only with the help of 
additional cis-acting elements, named “splicing enhancers” 
and “splicing silencers.” Usually, any given region of a pre-mRNA 
contains, in addition to various potential exon–intron boundaries, 
several splicing enhancers and silencers that antagonize each 
other (Black, 2003). This enormous body of information is de-
coded by two families of RNA-binding proteins: the serine/ 
arginine (SR) proteins and the heterogenous nuclear RNPs 
(hnRNPs; Black, 2003; Matlin et al., 2005). The SR proteins 
consist of one or two RNA-binding domains and a domain 
rich in SR dipeptides. They bind to splicing enhancers and 
  usually activate splicing at nearby splice sites. The hnRNPs 
bind mostly, but not always, to splicing silencers and there-
fore inhibit splicing at nearby splice sites. Thus, the fate of 
a pre-mRNA region is usually decided by the antagonism be-
tween hnRNP and SR proteins (for review see Matlin et al., 
2005). The best-described example is the antagonism between 
the SR protein ASF/SF2 and hnRNP A1. The ratio of ASF/SF2 
to hnRNP A1 determines the usage of splice sites, because 
ASF/SF2 recruits the U1 small nuclear RNP to the pre-mRNA, 
a crucial step in establishing a 5′ splice site, whereas hnRNP 
A1 counteracts U1 binding (Eperon et al., 2000). However, the 
limited number of hnRNP and SR proteins, as well as their 
limited binding specifi  city for the pre-mRNAs, cannot faith-
fully determine splicing in so many pre-mRNAs (Singh and 
Valcarcel, 2005). Additional proteins are likely required to 
confer specifi  city to the regulation of alternative splicing in 
live cells and to decipher the signaling pathways triggered by 
environmental cues.
A well-suited candidate to integrate signal transduction 
pathways and RNA metabolism is Sam68. This RNA-binding 
protein belongs to the signal transduction and activation of 
RNA (STAR) metabolism family (Vernet and Artzt, 1997; 
  Lukong and Richard, 2003), and it was fi  rst identifi  ed as a target 
of the tyrosine kinase Src (Fumagalli et al., 1994; Taylor and 
Shalloway, 1994). STAR proteins are characterized by a KH 
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T
he RNA-binding protein Sam68 is involved in 
apoptosis, but its cellular mRNA targets and its 
mechanism of action remain unknown. We demon-
strate that Sam68 binds the mRNA for Bcl-x and affects 
its alternative splicing. Depletion of Sam68 by RNA 
inter  ference caused accumulation of antiapoptotic Bcl-
x(L), whereas its up-regulation increased the levels 
of proapoptotic Bcl-x(s). Tyrosine phosphorylation of 
Sam68 by Fyn inverted this effect and favored the 
Bcl-x(L) splice site selection. A point mutation in the 
RNA-binding   domain of Sam68 influenced its splicing 
activity and subnuclear localization. Moreover, co-
expression of ASF/SF2 with Sam68, or fusion with an RS 
domain, counteracted Sam68 splicing activity toward 
Bcl-x.   Finally, Sam68 interacted with heterogenous 
  nuclear RNP (hnRNP) A1, and depletion of hnRNP A1 or 
muta  tions that impair this interaction attenuated Bcl-x(s) 
  splicing. Our results indicate that Sam68 plays a role 
in the regulation of Bcl-x alternative splicing and that 
  tyrosine phosphorylation of Sam68 by Src-like kinases 
can switch its role from proapoptotic to antiapoptotic in 
live cells.
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(hnRNP K homology) domain embedded in a highly conserved 
region called GSG (GRP33/Sam68/GLD1) domain, which is 
required for homodimerization and sequence-specifi  c  RNA 
binding (Lin et al., 1997; Chen et al., 1999). Sam68 has been 
implicated in the regulation of cell cycle progression and apop-
tosis (Taylor et al., 2004; Babic et al., 2006). The subcellular 
  localization and the affi  nity of Sam68 for RNA are regulated 
by posttranslational modifi  cations, like phosphorylation and 
methylation (Wang et al., 1995, Cote et al., 2003; Paronetto 
et al., 2003; Lukong et al., 2005). The localization of Sam68 
is   predominantly nuclear, suggesting a function in pre-mRNA 
processing. A role for Sam68 in alternative splicing was demon-
strated by its ability to induce inclusion of the variable exon v5 
in the CD44 mRNA (Matter et al., 2002). The activation of Ras 
in response to   phorbol ester stimulation triggered the phosphory-
lation of Sam68 by Erk1/2 and Sam68-dependent v5 inclusion 
in mouse T- lymphoma cells. More recently, it has been observed 
that Sam68 cooperates with the splicing activator SRm160 in 
the regulation of CD44 alternative splicing (Cheng and Sharp, 
2006). In addition, Sam68 was found to associate with Brm, 
a component of the SWI/SNF chromatin remodeling complex 
(Batsché et al., 2006), suggesting that it may participate in 
  splicing events during the initial stages of CD44 pre-mRNA 
synthesis. Aside from CD44 alternative splicing, no information 
is available on other pre-mRNAs that could be regulated by this 
protein. Given the role of Sam68 in the regulation of apoptosis, 
it would be important to identify cellular targets involved in 
such a process.
Alternative splicing plays a crucial role in the control of 
apoptosis. Several pre-mRNAs for cell death factors are alter-
natively spliced, yielding isoforms with opposing functions 
during programmed cell death (Schwerk and Schultze-Osthoff, 
2005). A clear example is the Bcl-x transcript, which is alter-
natively spliced to produce the antiapoptotic Bcl-x(L) or the 
proapoptotic Bcl-x(s) (Boise et al., 1993). The choice of alter-
native splicing of Bcl-x pre-mRNA refl  ects the sensitivity of 
cells toward agents that induce apoptosis. For example, cancer 
cells often up-regulate the antiapoptotic Bcl-x(L) isoform, and 
this event is associated with increased risk of metastasis, reduced 
sensitivity to chemotherapeutic treatments, and poor prognosis 
(Clarke et al., 1995; Olopade et al., 1997). On the other hand, 
treatment of cancer cells expressing high levels of Bcl-x(L) 
with antisense oligonucleotides complementary to the Bcl-x(L) 
splice site favor the expression of Bcl-x(s) and sensitize cells to 
undergo apoptosis (Mercatante et al., 2002). These observations 
strongly indicate that manipulation of Bcl-x alternative splicing 
may have important applications in cancer treatment. However, 
despite the crucial importance of this process, little information 
is available on splicing regulators controlling splice site se-
lection of Bcl-x pre-mRNA. Recent reports have shown that 
hnRNP F/H induce Bcl-x(s) expression (Garneau et al., 2005), 
whereas SAP155 is required for selection of the Bcl-x(L) splice 
site (Massiello et al., 2006). Moreover, the ratio between the two 
isoforms can be shifted toward Bcl-x(s) by an increase in 
  ce  ramide (Chalfant et al., 2002). Hence, cells can quickly switch 
to an apop  totic program as a consequence of altered growth 
con  ditions through a change in splice site selection of the Bcl-x 
pre-mRNA.
In the present work, we have investigated the role of the 
RNA-binding protein Sam68 in the regulation of apoptosis. We 
have identifi  ed the fi  rst cellular targets of Sam68 involved in 
apoptosis and provide evidence that Sam68 favors the selection 
of the Bcl-x upstream 5′ splice site and the production of the 
proapoptotic Bcl-x(s) isoform.
Results
Sam68 directly binds mRNAs 
for regulators of apoptosis
Sam68 is a RNA-binding protein whose intracellular levels 
regulate cell cycle progression and apoptosis (Taylor, et al., 
2004; Babic, et al., 2006). We set out to investigate whether 
Sam68 plays a direct role on the posttranscriptional regulation 
of mRNAs encoding known apoptotic regulators. Endogenous 
Sam68 was immunoprecipitated with an anti-Sam68 anti-
body from HEK293 cell extracts (Fig. 1 A) prepared under 
conditions that preserve RNA and RNPs (Paronetto et al., 
2006). RNA was extracted from the immunoprecipitates and an-
alyzed by RT-PCR for the presence of genes involved in the 
regulation of apoptosis. We found that Sam68 specifi  cally 
binds to the endogenous Bak, Bax, Bcl-x, and Bim mRNAs, 
but not to Bcl2 mRNA. Control immunoprecipitations with 
preimmune IgGs gave no enrichment in any of the mRNAs 
analyzed (Fig. 1 B). To test whether Sam68 can   recognize 
these mRNAs on its own, we purifi  ed GST-Sam68 from bac-
teria and total RNA from HEK293 cells and performed GST 
pull-down experiments. RT-PCR analysis showed that Sam68 
can directly bind to these mRNAs in a cell-free assay (Fig. 1 C).
Sam68 enhances Bcl-x(s) splicing in vivo
To date, the only cellular target identifi  ed for the splicing  activity 
of Sam68 is CD44 (Matter et al., 2002). Because Sam68 binds 
to the mRNA for Bcl-x, an apoptotic regulator known to un-
dergo alternative splicing (Boise et al., 1993), posttranscriptional 
Figure 1.  Endogenous Sam68 associates with the mRNAs encoding for 
regulators of apoptosis. 1 mg of HEK293 cell extracts was immunoprecipi-
tated with 10 μg of either control rabbit IgGs or anti-Sam68 IgGs as de-
scribed in Materials and methods. An aliquot of the immunoprecipitated 
proteins was analyzed in Western blot for the presence of Sam68 (A), and 
the remaining sample was extracted in phenol/chloroform after treatment 
with proteinase K and DNase. (B) Extracted RNA was retrotranscribed and 
used for PCR ampliﬁ  cation with oligonucleotides speciﬁ  c for the indicated 
genes. (C) GST pull-down experiment using puriﬁ  ed GST or GST-Sam68 
immobilized on glutathione-agarose beads and 100 μg of total RNA ex-
tracted and puriﬁ  ed from HEK293 cells. Adsorbed RNA was extracted, 
retrotranscribed, and ampliﬁ  ed as described in B.SAM68 AND BCL-X SPLICING • PARONETTO ET AL. 931
  regulation of this mRNA by Sam68 was   investigated further. 
Alternative splicing is usually governed by a delicate balance 
of activators and inhibitors of splice site   selection that have re-
dundant functions in the cell (Matlin et al., 2005; Singh and 
Valcarcel, 2005). Hence, we investigated whether changes in 
the intracellular concentration of Sam68 modulate the alterna-
tive splicing of Bcl-x in HEK293 cells. We found that down-
regulation of Sam68 by RNAi changed the   ratio of alternatively 
spliced Bcl-x isoforms, with an increase in the antiapoptotic 
Bcl-x(L) and a decrease in the proapoptotic Bcl-x(s) transcript 
(approximately twofold; Fig. 2 A, right). A decrease in Bcl-x(s) 
was observed also at the protein level after depletion of Sam68 
(Fig. 2 A, left).
As a second approach, we overexpressed GFP or GFP-
Sam68 constructs in HEK293 cells. GFP-positive cells were 
sorted, and cellular extracts were prepared for RT-PCR and 
Western blot analyses. Up-regulation of Sam68 caused an in-
crease in the Bcl-x(s)/Bcl-x(L) ratio at the mRNA level (4.5-
fold; Fig. 2 B). A similar increase in ratio was obtained by 
transfection of HEK293 cells with a Bcl-x(L) antisense oligo-
nucleotide (3.8-fold; Fig. 2 B). Up-regulation of Sam68 also in-
creased Bcl-x(s) protein (Fig. 2 B). These results demonstrate 
that fl  uctuations in the intracellular concentration of Sam68 af-
fect the alternative splicing of endogenous Bcl-x mRNA.
Sam68 enhances splicing of the Bcl-x 
minigene in a dose-dependent manner
To investigate the regulation of Bcl-x splicing by Sam68 in 
more detail, we used a Bcl-x minigene that spans the whole 
  alternatively spliced region from exon 1 to 3, with a shortened 
intron 2 (Fig. 2 C; Massiello, et al., 2004). Cotransfection of 
GFP-Sam68 with this reporter strongly enhanced the formation 
of the short variant of the Bcl-x transcript with respect to trans-
fection of GFP alone (Fig. 2 C). The selection of the upstream 
5′ splice site in exon 2 was stimulated in a dose-dependent 
manner when the Bcl-x minigene was cotransfected with in-
creasing amounts of GFP-Sam68 (Fig. 2 D). Hence, the Bcl-x 
minigene recapitulates the effects of Sam68 on the endogenous 
Bcl-x mRNA.
MAPK signaling does not affect 
Sam68-mediated Bcl-x alternative splicing
Phosphorylation of Sam68 by the MAPK Erk1/2 induces in-
clusion of exon v5 in the CD44 mRNA (Matter et al., 2002). 
To determine the effects of Erk1/2 signaling on Sam68-
  mediated splicing of Bcl-x, HEK293 cells were transfected 
with GFP or GFP-Sam68 and treated with selective inhibitors 
of the MAPK pathway. We observed that neither U0126, which 
blocks activation of Erk1/2 by MEK, nor JNK inhibitor 1, 
which blocks activation of the JNK family of MAPKs that are 
also involved in alternative splicing (Pelisch et al., 2005), sub-
stantially affected Sam68-mediated selection of the 5′ splice 
site in the Bcl-x minigene (Fig. S1 B, available at http://www
.jcb.org/cgi/content/full/jcb.200701005/DC1). Under these 
conditions, the localization of GFP-Sam68 was also not af-
fected (Fig. S1 A).
To determine whether constitutive activation of Erk1/2 
signaling affected Sam68-mediated Bcl-x alternative splicing, 
Figure 2.  Fluctuations in the intracellular lev-
els of Sam68 affect the alternative splicing of 
Bcl-x. (A) Knock down of Sam68 in HEK293 
cells was obtained by RNAi and veriﬁ  ed by 
Western blot analysis (top left). Samples were 
also stained with anti-Bcl-x (middle) and anti-
tubulin (bottom). Total RNA was extracted 
from these samples, and expression of Bcl-x 
alternatively spliced forms was determined by 
RT-PCR (top right). Densitometric analysis of 
the Bcl-x(s)/Bcl-x(L) ratio in three independent 
experiments was performed, and results are 
shown below the panel. (B) HEK293 cells 
were transfected with GFP or GFP-Sam68 and 
GFP-positive cells (left) or with a Bcl-x(L) anti-
sense oligo (right). GFP-expressing cells were 
isolated by cell sorting. Analysis of Bcl-x 
  mRNAs by RT-PCR is shown in the right panel. 
Densitometric analysis of the Bcl-x(s)/Bcl-x(L) 
ratio in three separate experiments was per-
formed, and results are shown below the 
panel. Western blot analysis of GFP-Sam68 
and of the Bcl-x isoforms are shown in the left 
panels. Actin staining of the blot was used as 
internal loading control. (C) Schematic dia-
gram of the Bcl-x minigene used. HEK293 
were transfected with 0.5 μg pCDNA3.1-Bcl-x 
minigene and 0.5 μg GFP-Sam68 or GFP as 
control. The effect on alternative splicing was 
detected by RT-PCR (panel below the scheme). 
(D) 0.5 μg pCDNA3.1-Bcl-x minigene and dif-
ferent amounts of GFP-Sam68 (0.02–0.3 μg) 
were also transfected. Cells were harvested 20 h later. RT-PCR of the samples was performed to determine the relative abundance of Bcl-x(L) and Bcl-x(s) 
mRNAs by densitometric analysis. Mean values ± SD of three independent experiments are shown. Anti-Sam68 Western blot (bottom) indicates the ex-
pression levels of endogenous (Sam68) and recombinant (GFP-Sam68) proteins.JCB • VOLUME 176 • NUMBER 7 • 2007  932
HEK293 cells were cotransfected with MEKK1 and suboptimal 
concentration of GFP-Sam68 (Fig. S1 D). Under these con-
ditions, Erk1/2 was activated by MEKK1 (Fig. S1 C, left). 
  Interestingly, activation of Erk1/2 signaling caused a partial re-
distribution of GFP-Sam68 in the cytoplasm (Fig. S1 A). Analysis 
of immunoprecipitated GFP or GFP-Sam68 by Western blot with 
phosphospecifi  c antibodies indicated that MEKK1 increased 
phosphorylation of Sam68 at serines, whereas threonine phos-
phorylation was already detected under basal conditions and 
only mildly affected by MEKK1 (Fig. S1 C, right). Sam68-
  mediated induction of Bcl-x(s) alternative splicing was only 
marginally affected in the presence of activated Erk1/2 (2.59 vs. 
2.04 in the x(s)/x(L) ratio; Fig. S1 D, left). To rule out the 
  possibility that the basal threonine phosphorylation of Sam68 
was suffi  cient to modulate its activity, a similar experiment was 
performed using wild-type myc-Sam68 or -Sam68m1, a mu-
tated version lacking the eight Erk1/2 phosphorylation sites 
of Sam68 (Matter et al., 2002). As illustrated in Fig. S1 D, we 
observed that myc-Sam68m1 was as effi  cient as the wild-type 
protein to favor the Bcl-x(s) 5′ splice site selection. These 
  results indicate that, different from what was observed with 
CD44, Erk1/2 signaling does not affect Sam68-mediated Bcl-x 
alternative splicing.
The tyrosine kinase Fyn modulates Sam68-
mediated alternative splicing of Bcl-x mRNA
Sam68 was originally identifi  ed as a substrate of Src in mito-
sis (Fumagalli et al., 1994; Taylor and Shalloway, 1994), and 
  tyrosine phosphorylation of Sam68 by the Src-like kinase Fyn 
decreases its affi  nity for synthetic homopolymeric RNA in 
  vitro (Wang et al., 1995). Hence, we asked whether tyrosine 
phosphorylation affected the splicing activity of Sam68 toward 
a cellular target. Coexpression of wild-type Fyn counteracted 
the ability of GFP-Sam68 to favor the Bcl-x(s) 5′ splice site 
selection, resulting in an isoform ratio similar to the GFP 
  control (Fig. 3 B). Remarkably, the constitutively active mutant 
FynY528F (Sette et al., 2002), which induces a stronger tyrosine 
phosphorylation of Sam68 (Fig. 3 B), completely reverted the 
effect and induced predominant selection of the Bcl-x(L) 
5′ splice site in a Sam68-dependent manner (Fig. 3 B, bar 
graph). Both Fyn and FynY528F caused the relocalization of 
Sam68 from a diffuse distribution in the nucleoplasm to 
  discrete   subnuclear foci (Fig. 3 A). No effect of Fyn on Bcl-x 
splic  ing were observed when Sam68 was not overexpressed. 
  Because the endogenous Sam68 was not strongly tyrosine pho  s-
phorylated under these conditions (20 h after transfection), we 
  performed splicing assays after prolonged Fyn expression. 
  Remarkably, tyrosine phosphorylation of the endogenous 
Sam68 was strongly increased 48 h after transfection of Fyn 
(Fig. 3 C). In these cells, the effects of Fyn on Bcl-x minigene 
splicing were similar to those obtained with overexpressed 
Sam68 (Fig. 3 C), indicating that tyrosine phosphorylation of 
endogenous Sam68 affects Bcl-x splicing. Moreover, a similar 
regulation of Bcl-x isoform ratio was also observed with 
  endogenous mRNAs (Fig. S2, available at http://www.jcb.org/
cgi/content/full/jcb.200701005/DC1). Next, we asked whether 
Figure 3.  Tyrosine phosphorylation of Sam68 
by Fyn modulates the alternative splicing of 
Bcl-x.  (A) Live-cell images of HEK293 cells 
transfected with wild-type GFP-Sam68 either 
alone or in combination with Fyn or FynY528F, 
as indicated. Bars, 10 μm. (B) Splicing assay 
of the Bcl-x minigene (0.5 mg) in HEK293 cells 
transfected with 0.25 mg of either GFP or GFP-
Sam68 alone or in combination with 0.25 mg 
Fyn or FynY528F. Cells were harvested 20 h 
  after transfection and processed for RT-PCR. 
Densitometric analysis of three independent 
experiments are shown below the image 
(mean values ± SD of the Bcl-x(s)/Bcl-x(L) 
  ratio). Cell extracts of the same samples were 
analyzed in Western blot for GFP (top), tyro-
sine phosphorylation with the PY20 antibody 
(middle; position of recombinant GFP-Sam68 
and of endogenous Sam68 are indicated 
by arrows), and tubulin as loading control 
(bottom). (C) HEK293 cells were transfected with 
the Bcl-x minigene and empty pCMV5 (mock) 
or pCMV5-Fyn (Fyn). After 48 h, cells were 
harvested and used for Bcl-x RT-PCR (left) or 
Western blot analysis as in B. Bcl-x(s)/x(L) ratio 
of three independent experiments is shown in 
the bar graph. (D) Coimmunoprecipitation of 
Sam68 with Bcl-x endogenous mRNA from 
HEK293 cells transfected with GFP or GFP-
Sam68 either alone or in combination with 
Fyn to induce tyrosine phosphorylation. Cell 
  extracts were immunoprecipitated with the GFP 
antibody, and coprecipitated RNA was extracted 
and used for RT-PCR (top). An aliquot of the 
  immunoprecipitates was saved for Western 
blot analysis of Sam68 (middle) and of tyro-
sine phosphorylation (bottom).SAM68 AND BCL-X SPLICING • PARONETTO ET AL. 933
tyrosine phosphorylation by Fyn also affected the binding of 
Sam68 to the endogenous Bcl-x mRNA. Bcl-x mRNA was 
  coimmunoprecipitated with GFP-Sam68 but not with GFP 
(Fig. 3 D). Coexpression of Fyn abolished binding of Bcl-x mRNA 
to GFP-Sam68 (Fig. 3 D), indicating that tyrosine phosphoryla-
tion reduces the affi  nity of Sam68 for this cellular target in 
live cells.
A novel mutation in the RNA-binding 
domain of Sam68 affects Bcl-x splicing
A specifi  c mutation (V276F) in the GSG domain of the Sam68 
homologue GLD-1 (Jones and Schedl, 1995) affects germ 
cell apoptosis after DNA damage in Caenorhabditis elegans 
(Schumacher et al., 2005). Because this valine residue (V229) 
is conserved in human Sam68, we generated the homologous 
  mutant allele (GFP-Sam68V229F) and tested its activity toward 
Bcl-x splicing. First, the RNA-binding activity was tested in 
 vitro by pull-down assays with synthetic homopolymeric RNA. 
Both wild-type and mutant Sam68 bound to polyU-Sepharose 
beads with approximately the same affinity (see Fig. 6 B). 
By contrast, Sam68V229F was defective in binding to polyA–
 Sepharose  beads (see Fig. 6 B), indicating that this mutation 
  affects the RNA-binding specifi  city of the protein. To test the 
effect on splicing, wild-type and mutant GFP-Sam68 were 
coex  pressed with the Bcl-x minigene. Remarkably, Sam68V229F 
was   completely unable to favor the selection of the Bcl-x(s) 
5′ splice site. Rather, its expression enhanced the selection of the 
Bcl-x(L) 5′ splice site (Fig. 4 B). Moreover, unlike the wild-
type protein, Sam68V229F was unable to favor the expression of 
the endogenous Bcl-x(s) mRNA (Fig. 4 C). Densitometric 
analysis (Fig. 4 D) and real-time PCR quantifi  cation (Fig. 4 E) 
of RNA coimmunoprecipitation experiments showed that 
Sam68V229F was partially defective in binding to endogenous 
Bcl-x mRNA. Interestingly, we also observed that Sam68V229F 
localized to discrete nuclear foci and was not diffused in the 
  nucleoplasm like wild-type Sam68 (Fig. 4 A). Confocal micro-
scopy showed that these foci were different from the speckles 
where splicing factors like SC35 and ASF/SF2 accumulate 
(Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200701005/DC1). On the other hand, the localization of 
Sam68V229F was similar to that observed when wild-type Sam68 
was coexpressed with activated Fyn. Because in both condi-
tions the Bcl-x(L) 5′ splice site was favored, these results sug-
gest an inverse correlation between splice site modulation by 
Sam68 and its localization to subnuclear foci. Importantly, 
Sam68NLS-KO, in which two arginine residues in the nuclear lo-
calization signal (Wu et al., 1999) were substituted (R436A/
R442A), did not   affect splicing of Bcl-x (compared with GFP 
alone), indicating that nuclear localization of Sam68 is re-
quired to modulate splice site selection of Bcl-x pre-mRNA 
(Fig. 4, A and B).
Modulation of Bcl-x splicing 
by Sam68 correlates with its ability 
to induce apoptosis
Next, the correlation between Sam68 activity toward Bcl-x splic ing 
and induction of apoptosis was investigated. Similar to what is 
reported in NIH3T3 cells (Taylor et al., 2004), up-regulation of 
Sam68 induced apoptosis in HEK293 cells, as   determined by 
annexin V binding (Fig. 5 A), nuclear fragmentation (Fig. 5 B), 
and cleavage of caspase 3 (Fig. 5 C). Induction of apoptosis 
was similar to that elicited by transfection of the Bcl-x(L) anti-
sense oligonucleotide (Fig. 5 A), which affects the Bcl-x(s)/
Bcl-x(L) ratio similarly to Sam68 (Fig. 2 B). On the other hand, 
Sam68V229F and Sam68NLS-KO, which did not induce Bcl-x(s), were 
unable to trigger apoptosis in the same experimental setting. These 
results indicate that modulation of Bcl-x alternative splicing by 
Sam68 strongly correlates with the   ability of the protein to elicit 
an apoptotic response.
Figure 4.  The V229F mutation in the GSG domain of Sam68 affects Bcl-x 
alternative splicing. (A) Live-cell images of HEK293 cells transfected with 
mutant GFP-Sam68 constructs as indicated. Bars, 10 μm. (B) Splicing 
  assay of the Bcl-x minigene in HEK293 cells transfected with the indicated 
constructs. Cells were harvested 20 h after transfection and processed for 
RT-PCR. The bar graph represents mean values ± SD of the Bcl-x(s)/Bcl-x(L) 
ratio from three independent experiments. (C) RT-PCR analysis of endog-
enous Bcl-x mRNA isoforms in HEK293 cells transfected with wild-type 
or mutant GFP-Sam68 and sorted for GFP. The panel is a representative 
  experiment. The bar graph represents mean values ± SD of the Bcl-x(s)/Bcl-x(L) 
ratio from three independent experiments. (D) Extracts from HEK293 
cells transfected with the indicated constructs were immunoprecipitated 
with anti-GFP antibody, and coprecipitated RNA was extracted and used 
for conventional RT-PCR (top). An aliquot of the immunoprecipitates was 
analyzed by Western blot (bottom). Densitometric analysis of the RT-PCR 
from three independent experiments is shown in the bar graph (mean 
  values ± SD). (E) Samples described in D were analyzed by quantitative 
real-time PCR. The bar graph represents the mean ± SD of three experiments. 
Data are presented as ratio of the value: GFP-Sam68/GFP.JCB • VOLUME 176 • NUMBER 7 • 2007  934
Opposite actions of Sam68 and 
the SR protein ASF/SF2 in Bcl-x 
alternative splicing
Our results demonstrate that Sam68 affects the choice of Bcl-x 
splice sites in live cells. Normally, the Bcl-x(L) isoform is ex-
pressed predominantly. Sam68 could either antagonize or favor 
the recruitment of SR proteins in the vicinity of the Bcl-x splice 
sites. To test these hypotheses, we attempted to shift the balance 
between Sam68 and SR proteins. Our previous results already 
showed that silencing Sam68 by RNAi increased Bcl-x(L) 
splicing (Fig. 2 A). Next, we checked whether up-regulation 
of ASF/SF2, a prototypical SR protein that is essential for cell 
survival (Li et al., 2005), exerted the same effect. Indeed, co-
expression of ASF/SF2 induces virtually exclusive usage of the 
Bcl-x(L) splice site in the reporter minigene. When GFP-Sam68 
is also expressed, ASF/SF2 prevails but the Bcl-x(L) is no longer 
exclusively selected. Up-regulation of ASF/SF2 did not affect 
the diffuse localization of GFP-Sam68 in HEK293 cells (Fig. 6 A). 
This result suggests that Sam68 does not function by recruiting 
SR proteins to the Bcl-x(s) splice site. If this is true, forced 
  recruitment of a RS domain by Sam68 should not improve its 
splicing activity. To confi  rm this, we artifi  cially fused the RS 
domain of ASF/SF2 to GFP-Sam68. The resulting fusion 
  protein retains its RNA-binding activity, as measured by polyA 
and polyU pull-down assays (Fig. 6 B), indicating that its RNA-
binding motif is not aberrantly folded. Nevertheless, the in vivo 
splicing assay indicated that the RS domain neutralized, rather 
than increased, the splice site modulating activity of Sam68 
(Fig. 6 C). Interestingly, GFP-Sam68-RS was only par  tially 
  diffused in the nucleoplasm, whereas a portion of the protein 
accumulated in foci similar to those observed with GFP-
Sam68V229F (Fig. 6 A) but different from SC35 and ASF/SF2 
speckles (Fig. S3).
Next, we investigated the effect of the coexpression of 
Sam68 and ASF/SF2 on apoptosis. Remarkably, we found again 
a close correlation between Bcl-x splicing and apoptosis. ASF/
SF2 up-regulation almost completely suppressed the number of 
annexin V–positive cells (Fig. 6 D) and nuclear fragmentation 
(Fig. 6 E). In line with their effect on Bcl-x splicing, expression 
of GFP-Sam68-RS or coexpression of ASF/SF2 with Sam68 
strongly reduced the number of apoptotic cells.
Sam68 interacts with hnRNP A1 
in HEK293 cells
Alternative splicing is regulated by the concerted action of  several 
splicing regulators (Matlin et al., 2005). To investigate whether 
Sam68 interacted with other splicing factors in HEK293 cells, the 
endogenous protein was immunoprecipitated, and the presence of 
associated factors was tested by Western blot analysis. As shown 
in Fig. 7 B, endogenous Sam68 did not interact with SAP155 and 
hnRNP F/H, two splicing regulators that were recently reported 
to affect Bcl-x alter  native splicing (Garneau et al., 2005; Massiello 
et al., 2006), or with ASF/SF2. By contrast, we found that Sam68 
specifi   cally interacted with hnRNP A1, a splicing regulator 
known to   antagonize the function of ASF/SF2 (Eperon et al., 
2000). A similar interaction with hnRNP A1 was also observed 
with transfected Sam68 (Fig. 7 C). Confocal microscopy showed 
that GFP-Sam68 and hnRNP A1 were both diffused in the 
  nucleoplasm and that they partially colocalized in some nuclear 
foci (Fig. 7 A, arrows). On the other hand, neither colocalization 
(Fig. 7 A) nor interaction (Fig. 7, B and C) was observed between 
ASF/SF2 and Sam68. The association between Sam68 and 
hnRNP A1 was only slightly affected by RNase treatment (Fig. 7 D). 
To confi  rm a protein–protein interaction between them, we per-
formed pull-down assays. Bacterially purifi  ed GST fusion proteins 
containing different regions of Sam68 were incubated in vitro 
with HEK293 nuclear extracts. As shown in Fig. 7 E, hnRNP A1 
strongly bound to the C-terminal region of Sam68 (276–443), 
which does not contain the RNA-binding domain. The minimal 
region required for binding was mapped to the last 93 amino 
  acids of Sam68 (351–443). On the other hand, the N-terminal 
  region of Sam68 (1–277), containing the whole GSG domain, 
Figure 5.  Sam68-mediated alternative splicing of Bcl-x correlates with 
  induction of apoptosis. (A) HEK293 cells were transfected with the indicated 
constructs and harvested after 48 h to be processed for annexin V–PE staining. 
The percentage of annexin V–positive cells is referred to the GFP-positive 
population. Data are the mean ± SD of three separate experiments. (B and C) 
HEK293 cells transfected as in A were examined 72 h after transfection. 
Nuclear fragmentation (B), judged as indicated by the two cells indicated 
by arrows in the left panels, was scored in the GFP-positive cells. Data 
were obtained by counting at least 200 cells for each sample in ﬁ  ve dif-
ferent ﬁ  elds and represent the mean ± SD of three separate experiments. 
Bars, 10 μm. (C) The bar graph represents the percentage of cells posi-
tive in immunoﬂ  uorescence for the activated (cleaved) caspase 3 in the 
GFP-positive population. The results are the mean ± SD of three inde-
pendent experiments (at least 500 cells for each sample were counted in 
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weakly bound to hnRNP A1, suggesting that weak interaction 
through a common RNA could also occur. No binding to GST 
alone was observed. These results indicate that Sam68 and 
hnRNP A1 can form a protein–protein interaction.
To test whether association between Sam68 and hnRNP 
A1 was inhibited by conditions in which Bcl-x(L) splicing was 
favored, we tested the coimmunoprecipitation in the presence 
of Fyn or with GFP-Sam68 mutant proteins. Remarkably, we 
found that neither GFP-Sam68V229F nor GFP-Sam68-RS was 
able to associate (Fig. 8 A) or colocalize (Fig. S3) with hnRNP 
A1 and that this interaction was strongly reduced when wild-
type Sam68 was phosphorylated on tyrosine by coexpression of 
Fyn (Fig. 8 A). To determine whether hnRNP A1 expression in-
fl  uences the Sam68 effects, we depleted hnRNP A1 by RNAi. 
HEK293 was transfected with hnRNP A1 siRNAs or scrambled 
controls 24 h before transfection with the Bcl-x minigene and 
GFP or GFP-Sam68. We observed that depletion of hnRNP A1 
attenuated Sam68-induced Bcl-x(s) splicing (Fig. 8 B). Remark-
ably, annexin V staining indicated that depletion of hnRNP A1 
also reduced the number of apoptotic cells elicited by Sam68 
transfection (Fig. 8 C). These results suggest that hnRNP A1 
and Sam68 cooperate to modulate the alternative splicing of 
Bcl-x and apoptosis in live cells (Fig. 8 D).
Discussion
The RNA-binding protein Sam68 has recently been proposed 
to regulate apoptosis (Taylor et al., 2004; Babic et al., 2006). 
However, no direct evidence on the mRNAs regulated by Sam68 
during induction of apoptosis or on the mechanisms involved 
in this process has been provided. The results presented herein 
  indicate that regulation of apoptosis by Sam68 involves changes 
in alternative splicing of its cellular target, Bcl-x. We provide 
evidence that Sam68 binds to endogenous Bcl-x mRNA and 
that fl  uctuations in the intracellular levels of this RNA-binding 
protein affect the ratio between the antiapoptotic Bcl-x(L) 
and the proapoptotic Bcl-x(s) mRNA. Finally, by using mul-
tiple   experimental approaches, we show that posttranslational 
  modifications and point mutations affect both the splicing 
act  ivity of Sam68 toward Bcl-x and induction of apoptosis in 
live cells. Our work provides the fi  rst cellular target of Sam68 
involved in apoptosis and suggests a mechanism of action for 
this RNA-binding protein in response to an altered intra-
cellular environment.
The cellular targets of Sam68 potentially involved in apop-
tosis were identifi  ed by coimmunoprecipitation experiments. 
Using this approach, we have recently identified additional 
mRNAs that are targets of Sam68 in mouse male germ cells 
(Paronetto et al., 2006). The specifi  city of the binding was as-
sessed by a parallel immunoprecipitation with preimmune IgGs 
and by confi  rmation of the targets identifi  ed in pull-down assays 
using purifi  ed proteins and RNAs. More important, we show 
that fl  uctuations in Sam68 intracellular levels achieved by RNAi 
or transient transfection profoundly affect alternative splicing 
of one of these targets: Bcl-x. An increase of Sam68 shifts the 
balance toward the proapoptotic Bcl-x(s) isoform, and there 
is a correlation between Sam68-induced Bcl-x(s) splicing and 
apoptosis. However, as Sam68 binds the mRNAs for other regu-
lators of apoptosis, it is possible that its effects on cell death 
also   involve the regulation of additional targets.
STAR proteins are thought to link signal transduction 
pathways to mRNA processing (Vernet and Artzt, 1997). In-
deed, it was recently shown that ser/thr phosphorylation of 
Sam68 by Erk1/2 affected exon v5 inclusion in the CD44 
Figure 6.  Opposite actions of Sam68 and 
ASF/SF2 in Bcl-x alternative splicing. (A) Live-
cell images of HEK293 cells transfected with 
the indicated constructs encoding GFP-Sam68 
variants and ASF/SF2. Bars, 10 μm. (B) Extracts 
from HEK293 cells transfected as indicated 
were incubated with either polyA- or polyU-
Sepharose beads, and adsorbed proteins 
were analyzed in Western blot with the anti-
Sam68 antibody. (C) Splicing assay of the 
Bcl-x minigene in HEK293 cells transfected 
with the indicated constructs. Cells were har-
vested 20 h after transfection and processed 
for RT-PCR. The experiment shown is represent-
ative of three independent experiments. Mean 
values ± SD of the Bcl-x(s)/Bcl-x(L) ratio are 
shown below the panel. (D) HEK293 cells 
were transfected with the indicated constructs 
and harvested after 48 h (for annexin V–PE 
staining) or (E) counted 72 h (for nuclear frag-
mentation) after transfection. Annexin V stain-
ing and nuclear fragmentation were assessed 
as described in the legend to Fig. 6. Data are 
the mean ± SD of three separate experiments.JCB • VOLUME 176 • NUMBER 7 • 2007  936
mRNA (Matter et al., 2002). Surprisingly, we found that Erk1/2 
signaling does not strongly affect Sam68-mediated alternative 
splicing of Bcl-x, suggesting that posttranslational modifi  ca-
tions of this RNA-binding protein may differentially regulate its 
mRNA targets. By contrast, we found that tyrosine phosphory-
lation of Sam68 by the Src-like kinase Fyn reverts the ratio of 
Bcl-x(s)/Bcl-x(L) induced by Sam68 and promote the expres-
sion of the antiapoptotic Bcl-x(L) mRNA. The same effect was 
also achieved by creating the V229F substitution or by fusing an 
RS domain to Sam68. Intriguingly, in all these cases, the local-
ization of Sam68 changed from being diffuse in the nucleoplasm 
to accumulating in discrete subnuclear foci that are different 
from the speckles where SC35 and ASF/SF2 accumulate. These 
observations   suggest that Sam68 is in a dynamic equilibrium in 
the nucleus and that posttranslational modifi  cations affect both 
the localization and the activity of the protein, resulting in alter-
native processing of its pre-mRNA targets.
The activity of Src-like kinases is often up-regulated in 
cancer cells and contributes to cell proliferation, survival, 
and invasiveness (Irby and Yeatman, 2000). Src activity is up-
regulated in human prostate carcinomas at advanced stages, and 
it correlates with tyrosine phosphorylation of Sam68 (Paronetto 
et al., 2004). A similar observation was made in breast can-
cer cells (Lukong et al., 2005), suggesting that it is a common 
mechanism of control of this protein in neoplastic cells. Our 
  results provide a possible explanation for these observations. 
Tyrosine phosphorylation of Sam68 in cancer cells may protect 
them from apoptosis by altering the Bcl-x(s)/Bcl-x(L) ratio in 
favor of Bcl-x(L) (Fig. 3). In line with this hypothesis, it has 
been shown that Bcl-x(L) levels are increased in more aggres-
sive prostate cancer cells and that their treatment with synthetic 
  oligonucleotides that promote the Bcl-x(s) splice site selection 
in the pre-mRNA triggers apoptosis (Mercatante et al., 2002). 
It is possible that Sam68 participates in the mechanisms that 
  render prostate cancer cells more resistant to apoptosis and 
that treatments affecting tyrosine phosphorylation of Sam68 
can infl  uence survival of cancer cells expressing high levels 
of Bcl-x(L).
The experiments presented herein demonstrate for the 
fi  rst time that Sam68 can interact with hnRNP A1. Interestingly, 
we found that tyrosine phosphorylation by Fyn, or mutations 
like V229F and fusion to a RS domain, disrupted this complex 
and affected Bcl-x(s) splicing. Moreover, depletion of hnRNP 
A1 by RNAi strongly attenuated Sam68-induced Bcl-x(s) splic-
ing and apoptosis, suggesting that the interaction between 
Sam68 and hnRNP A1 is functionally relevant. The interaction 
between Sam68 and hnRNP A1 is only in part mediated by 
RNA, suggesting that these proteins could bind cooperatively to 
pre-mRNAs. Thus, hnRNP A1 might be recruited to certain 
pre-mRNA regions by the presence of Sam68 in the vicinity. 
Although future mechanistic experiments are required to defi  ne 
this functional interaction, we hypothesize that Sam68 may 
  affect Bcl-x splicing by attracting hnRNP A1, which is known 
to compete with ASF/SF2 and to cause switches in 5′ splice 
sites (Eperon et al., 2000). Generally, there are rather few pro-
teins that infl  uence splice site selection, compared with the 
number of regulated alternative splice events. It has been postu-
lated that the choice of splice sites is governed by combinations 
of splice factors, rather than individual proteins (Matlin et al., 
2005; Singh and Valcarcel, 2005), but practical examples of 
  interactions between splice factors remain few. Thus, the inter-
action of Sam68, a tightly regulated RNA-binding protein, with 
Figure 7.  Sam68 associates with hnRNP A1 
in HEK293 cells. (A) Confocal images of GFP-
Sam68 and endogenous ASF/SF2 (top) or 
  hnRNP A1 (bottom). Arrows in the bottom 
  panels show perinucleolar foci in which 
Sam68 and hnRNP A1 colocalize. Bars, 10 μm. 
(B) Western blot analysis of the coimmuno-
precipitation between endogenous Sam68 or 
myc-Sam68 (C) and the indicated endogenous 
splicing factors. (D) Western blot analysis of 
the association between Sam68 and hnRNP 
A1 in the presence of RNase. (E) Pull-down 
  assay of hnRNP A1 with GST fusion proteins of 
fragments of Sam68. (top) Anti–hnRNP A1 
Western blot; (bottom) Coomassie blue staining 
of the same samples.SAM68 AND BCL-X SPLICING • PARONETTO ET AL. 937
an abundant factor that has a function in splice site selection, 
may well become a paradigm in regulated alternative splicing.
In conclusion, the experiments presented herein demon-
strate that Sam68 affects the alternative splicing of Bcl-x pre-
mRNA and suggest that perturbations of intracellular signaling 
pathways affecting its tyrosine phosphorylation status can fi  nely 
tune the splicing activity of Sam68 and predispose the cell to 
survive or to undergo programmed cell death.
Materials and methods
Plasmid constructs
The Bcl-x minigene has been described previously (Massiello, et al., 2004). 
The cDNA of human Sam68 was subcloned from pcDNA3-Sam68 
(Paronetto, et al., 2003) into EcoRI–SalI restriction site of pEGFP. Site-
  directed mutations were inserted by PCR using oligonucleotides containing 
the mutated residue (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200701005/DC1). Wild-type and mutated Sam68 cDNAs were 
also subcloned into pCDNA3-myc eukaryotic expression vector. The hu-
man ASF/SF2 cDNA (available from GenBank/EMBL/DDBJ under accession 
no. NM_006924) was ampliﬁ  ed by RT-PCR using Proofstart polymerase 
(Pfu; Stratagene) and HEK293 RNA. The cDNA was subcloned into SalI–
XbaI restriction sites of p3XFLAG (Sigma-Aldrich). GFP-Sam68-RS was 
generated by fusing the RS domain of ASF/SF2 (aa 194–248) to the 
C terminus of Sam68. The cDNA encoding the RS domain of ASF/SF2 was 
ampliﬁ  ed by PCR and subcloned into SalI–BamHI restriction sites of pEGFP 
in fusion with Sam68 upstream of the TAA codon. All cDNAs used in the 
experiments were sequenced by Cycle Sequencing (BMR Genomics). 
  Expression vector for Sam68m1, containing the phosphorylation mu-
tated sites, was provided by H. Konig (Institut für Toxikologie und Gnetik, 
Karlsruhe, Germany).
Cell cultures and transfections
HEK293 cells were maintained in DME (Invitrogen) supplemented with 
10% FBS (BioWhittaker Cambrex Bioscience), penicillin, and streptomycin. 
For transfections, HEK293 cells were plated in 35-mm dishes 1 d before 
and transfected with 1 μg of DNA (Bcl-x minigene, pEGFP-Sam68wt, 
pEGFP-Sam68V229F, pEGFP-Sam68NLSKO, pEGFP-Sam68RS, pFLAG-Asf/SF2, 
pCMV5-Fyn, pCMV5-FynY528F, pCDNA3-MEKK1, pCDNA3-  myc-Sam68, 
pCDNA3-myc-Sam68V229F) using lipofectamine 2000 (Invitrogen) according 
to the manufacturer’s instructions. At 24 h after transfections, cells were 
collected for RNA or biochemical analysis. For RNAi, cells at  50/60% con-
ﬂ  uence were transfected with siRNAs (MWG Biotech) using Oligofectamine 
and Opti-MEM medium (Invitrogen). Transfections were performed for 
2 or 3 consecutive days. Sequences for Sam68 and hnRNP A1 siRNAs 
are listed in Fig. S4. Transfection of antisense Bcl-x(L) oligonucleotide 
(Calbiochem) was performed as for RNAi using Oligofectamine.
Extraction of RNA and proteins from cultured cells
Total RNA was extracted from transfected HEK293 cells using cold Trizol 
reagent (Invitrogen), according to the manufacturer’s instructions. RNA 
was resuspended in RNase-free water (Sigma-Aldrich) and immediately 
frozen at −80°C for further analysis.
For protein extraction, HEK293 cells were resuspended in lysis 
  buffer (100 mM NaCl, 10 mM MgCl2, 30 mM Tris-HCl, pH 7.5, 1 mM 
  dithiothreitol, 10 mM β-glycerophosphate, 0.5 mM NaVO4, and protease 
inhibitor cocktail [Sigma-Aldrich]) supplemented with 0.5% Triton X-100. 
The extracts were centrifuged for 10 min at 12,000 g at 4°C, and the 
  supernatants were collected and used for Western blot or immunoprecipita-
tion experiments.
Immunoprecipitation experiments
HEK293 cells were homogenized in lysis buffer (100 mM NaCl, 10 mM 
MgCl2, 30 mM Tris-HCl, 1 mM DTT, protease inhibitor cocktail, and 40 U/ml 
RNase OUT [Invitrogen]) supplemented with 0.5% Triton X-100. Soluble 
extracts were separated by centrifugation at 10,000 g for 10 min, and 
they were precleared for 2 h on protein A–Sepharose beads (Sigma-
  Aldrich) in the presence of 2 μg rabbit IgGs, 0.05%BSA, and 0.1 μg/ml 
yeast tRNA. After centrifugation for 1 min at 1,000 g, supernatants were 
incubated with 2 μg anti-Sam68 (Santa Cruz Biotechnology, Inc.), anti-
GFP (Roche), or rabbit IgGs for 3 h at 4°C under constant rotation. Beads 
were washed three times with lysis buffer, and an aliquot was eluted in SDS 
sample buffer for Western blot analysis. The remaining beads were incu-
bated with lysis buffer in the presence of (RNase-free) DNase (Roche) for 
15 min at 37°C and washed three times with lysis buffer before incubation 
with 50 μg proteinase K (Roche) for an additional 15 min at 37°C. Co-
precipitated RNA was then extracted by standard procedure and used for 
RT-PCR using BclX-1 and rtBclX-2 primers (Fig. S4). For the coimmunoprecipita-
tion experiment with hnRNP A1, nuclear extracts were prepared by resuspending 
cells in ipotonic buffer (10 mM Tris/HCl, pH 7.4, 10 mM NaCl, 2.5 mM 
MgCl2, 1 mM DTT, protease inhibitor cocktail, 30 U/ml RNase OUT, 
Figure 8. hnRNP A1 expression favors 
Sam68-mediated Bcl-x(s) splicing. (A) Western 
blot analysis of the coimmunoprecipitation 
  between wild-type or mutant GFP-Sam68 and 
endogenous hnRNP A1 in the presence or 
  absence of Fyn. (B) Bcl-x minigene splicing 
  assays in HEK293 cells transfected with scram-
bled (scr) or hnRNP A1 siRNAs and either GFP 
or GFP-Sam68. (top) Western blot analyses of 
extracts from the same cells used in the right 
panel for the splicing assay. The bar graph 
  reports the densitometric analyses of the three 
experiments performed (mean ± SD). (C) Cells 
transfected as reported in B, but without the 
Bcl-x minigene, were stained for annexin V 
and analyzed by FACS. Data are reported 
as the mean ± SD of three independent 
  experiments. (D) Hypothetical model of the 
effects played by Sam68 and hnRNP A1 on 
Bcl-x alternative splicing.JCB • VOLUME 176 • NUMBER 7 • 2007  938
10 mM β-glycerophosphate, and 0.5 mM NaVO4). After incubation on ice 
for 7 min, samples were centrifuged at 700 g for 7 min. Pelleted nuclei 
were resuspended in ipotonic buffer supplemented with 90 mM NaCl and 
0.5% Triton X-100, sonicated, and stratiﬁ  ed on 30% sucrose. After a cen-
trifugation at 5,000 g for 15 min, nuclear extracts were precleared and 
immunoprecipitated as described. Where indicated, nuclear extracts were 
treated with 100 μg/ml RNase A (Sigma-Aldrich).
GST pull-down assay of the mRNA–Sam68 
and protein–protein interactions
For protein–protein interactions, GST and GST-Sam68 were puriﬁ  ed from 
Escherichia coli as previously described (Sette et al., 1998) and incubated 
for 1 h with nuclear extracts. For RNA–protein interactions, 2 μg of puri-
ﬁ  ed GST proteins were equilibrated for 1 h in 50 mM Tris-HCl, pH 7.4, 
100 mM KCl, 2 mM MgCl2, 1 mM EDTA, 1 mM DTT, 40 U/ml RNase 
OUT, and 0.2% Nonidet-P40 supplemented with 0.05% BSA and 0.1 μg/ml 
yeast tRNA. Puriﬁ  ed total RNA from HEK293 was added to the beads and 
incubated at 4°C under constant rotation. Beads were washed and RNA 
was extracted as described in the previous paragraph.
RT-PCR analysis
1 μg of RNA from HEK293 transfected cells or all of the coimmunoprecipi-
tated RNA was used for RT-PCR using M-MLV reverse transcriptase (Invitrogen) 
according to manufacturer’s instructions. 10% of the reverse-transcription 
reaction was used as template together with the following primers: endog-
enous Bcl-x, Bcl-X-1 (forward) and Bcl-X-2 (reverse); real-time PCR, rt-BclX-1 
(forward) and rt-BclX-2 (reverse); Bcl-x minigene, mg-BclX-1 (forward) and 
mg-BclX-2 (reverse). All primer sequences are listed in Fig. S4. Real-time PCR 
was performed using the iQ Sybr-green Supermix (Bio-Rad Laboratories) 
according to manufacturer’s instructions.
Western blot analysis
Cell extracts or immunoprecipitated proteins were diluted in SDS sample 
buffer and boiled for 5 min. Proteins were separated on 10% SDS-PAGE 
gels and transferred to Hybond-P membranes (GE Healthcare) as previ-
ously described (Sette et al., 2002). The following primary antibodies 
(1:1,000 dilution) were used (overnight at 4°C): rabbit anti-Sam68, rabbit 
anti-Erk2, rabbit anti-Fyn, and mouse anti-phosphotyrosine (PY20; Santa 
Cruz Biotechnology, Inc.); mouse anti-ASF/SF2 (US Biological); mouse 
anti–hnRNP A1, mouse anti-tubulin, and rabbit anti-actin (Sigma-Aldrich); 
mouse anti–hnRNP H/F (Abcam); rabbit anti–phospho-ERKs (Cell Signaling); 
rabbit anti-GFP (Roche); rabbit anti-phosphoserine and anti- phosphothreonine 
(Stressgen); and rabbit anti–Bcl-x (BD Biosciences). Secondary anti-mouse 
or anti-rabbit IgGs conjugated to horseradish   peroxidase (GE Healthcare) 
were incubated with the membranes for 1 h at room temperature at 
a 1:10,000 dilution in PBS containing 0.1% Tween 20. Immunos  tained 
bands were detected by chemiluminescent method (Santa Cruz Biotech-
nology, Inc.).
Annexin V staining
Transfected cells grown on 35-mm plates were harvested and processed 
for annexin V staining or for Western blot analysis. For annexin V staining, 
cells were washed in PBS and stained with the annexin V–PE (BD Bio-
sciences) according to the manufacturer’s instructions. GFP-positive cells were 
then analyzed with a FACSCalibur Flow Cytometer (Becton Dickinson).
Immunoﬂ  uorescence analysis
Transfected HEK293 cells were ﬁ  xed in 4% paraformaldehyde and washed 
three times with PBS. Cells were permeabilized with 0.1% Triton X-100 
for 7 min and incubated for 1 h in 0.5% BSA. Cells were washed three 
times with PBS and incubated for 2 h at room temperature with antibodies 
against cleaved casp3 (1:400; Sigma-Aldrich), SC35 (1:200; Sigma-
  Aldrich), Asf /SF2 (1:100), or hnRNP A1 (1:400), followed by 1 h of 
  incubation with cy3-conjugated anti-mouse IgGs (Chemicon). After washes, 
slides were mounted with MOWIOL reagent (Calbiochem) and analyzed 
by confocal microscopy using an inverted microscope (Carl Zeiss Micro-
Imaging, Inc.).
Image acquisition and manipulation
Images in Fig. 3 A, Fig. 4 A, Fig. 6 A, and Fig. S1 A were taken from 
an inverted microscope (IX70; Olympus) using an LCA ch 20×/0.40 
  objective. Images in Fig. 5 B were taken from a microscope (Axioskop; Carl 
Zeiss MicroImaging, Inc.) using a Pan-Neoﬂ  uar 40×/0.75 objective. Images 
were acquired at room temperature using a RT-slider camera (Diagnostic 
  Instruments) and the IAS2000 software (Biosistem82; Delta Sistemi). The con-
focal images in Fig. 7 A and Fig. S3 were taken from a confocal microscope 
(LSM510; Carl Zeiss MicroImaging, Inc.) using a Plan-  Neoﬂ  uar 40×/1.3 oil 
differential interference contrast objective and the LSM510 software (Carl Zeiss 
MicroImaging, Inc.). Images were   acquired as TIFF ﬁ  les, and Photoshop and 
Illustrator (Adobe) were used for composing the panels.
Online supplemental material
Fig. S1 shows that the ERK1/2 pathway does not regulate Sam68-  mediated 
alternative splicing of Bcl-x. Fig. S2 shows the effects of overexpressed Fyn 
on the alternative splicing of endogenous Bcl-x transcripts. Fig. S3 shows 
the localization of Sam68 mutants and splicing regulators in HEK293 cells. 
Fig. S4 shows a list of the oligonucleotides used for the PCR reactions in 
the article. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200701005/DC1.
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